Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
635.4 CHF | +0.19% | -.--% | +8.36% |
May. 22 | Swiss Equities Tumble as UK Inflation Data Dampens June Rate Cut Hopes | MT |
May. 22 | Swiss Life: at half-mast after quarterly update | CF |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- This company will be of major interest to investors in search of a high dividend stock.
- Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the past year, analysts have significantly revised downwards their profit estimates.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+8.36% | 20.02B | - | ||
+12.38% | 78.89B | B- | ||
+8.00% | 51.46B | B+ | ||
+7.77% | 51.07B | B | ||
+20.63% | 46.59B | B+ | ||
+15.34% | 43.21B | B+ | ||
+23.74% | 39.69B | B | ||
-1.34% | 29.1B | B | ||
-6.41% | 27.94B | B- | ||
-14.88% | 26.05B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- SLHN Stock
- SLHNE Stock
- Ratings Swiss Life Holding AG